These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4824772)

  • 1. Biochemical studies of a new antitumor agent, O2,2'-cyclocytidine.
    Ho DH
    Biochem Pharmacol; 1974 Apr; 23(8):1235-44. PubMed ID: 4824772
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
    Hoshi A; Kanzawa F; Kuretani K; Kanai T; Ichino M
    Biochem Pharmacol; 1973 Nov; 22(22):2829-34. PubMed ID: 4761553
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and pharmacologic studies with 1- -D-arabinofuranosylcytosine 5'-adamantoate (NSC-117614), a depot form of cytarabine.
    Neil GL; Buskirk HH; Moxley TE; Manak RC; Kuentzel SL; Bhuyan BK
    Biochem Pharmacol; 1971 Dec; 20(12):3295-308. PubMed ID: 5002403
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced antitumor effect of cytosine arabinoside given in a schedule dictated by kinetic studies in vivo.
    Young RC; Goldberg D; Schein PS
    Biochem Pharmacol; 1973 Jan; 22(2):277-80. PubMed ID: 4763256
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of neocarzinostatin on DNA synthesis in L1210 cells.
    Sawada H; Tatsumi K; Sasada M; Shirakawa S; Nakamura T
    Cancer Res; 1974 Dec; 34(12):3341-6. PubMed ID: 4473265
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor effects of bis-thiosemicarbazones--inhibition of deoxyribonucleic acid synthesis in vitro.
    Kessel D; McElhinney RS
    Biochem Pharmacol; 1975 Jan; 24(1):133-7. PubMed ID: 1092303
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor activity and mode of action of 2-thio-6-azauridine (NSC-146268) on L1210 leukemia.
    Li LH; Neil GL; Moxley TE; Olin EJ
    Cancer Chemother Rep; 1974; 58(3):345-52. PubMed ID: 4858297
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on camptothecin-induced degradation and apparent reaggregation of DNA from L1210 cells.
    Spataro A; Kessel D
    Biochem Biophys Res Commun; 1972 Aug; 48(3):643-8. PubMed ID: 5065404
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Veselý J; Pískala A
    Neoplasma; 1986; 33(1):3-10. PubMed ID: 2421173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 12. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075).
    Allen LM; Creaven PJ
    Cancer Res; 1973 Dec; 33(12):3112-6. PubMed ID: 4796799
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological and biochemical differences between tubercidin (7-deazaadenosine) and its 5'-phosphate methyl ester.
    Bhuyan BK; Neil GL; Smith CG; Olin EJ; Li LH
    Cancer Res; 1971 Dec; 31(12):1923-9. PubMed ID: 5120290
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations induced by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in deoxyribonucleic acid synthesis in normal and tumorous tissues. Implications for optimal chemotherapy.
    Rosenoff SH; Bostick F; Young RC
    Biochem Pharmacol; 1974 Nov; 23(22):3097-106. PubMed ID: 4441409
    [No Abstract]   [Full Text] [Related]  

  • 16. Some determinants of camptothecin responsiveness in leukemia L1210 cells.
    Kessel D
    Cancer Res; 1971 Dec; 31(12):1883-7. PubMed ID: 5120286
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific inhibition of DNA synthesis by cyclocytidine.
    Hoshi A; Yoshida M; Kanzawa F; Kuretani K; Kanai T
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2286-7. PubMed ID: 4675404
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical effects of ellipticine on leukemia L1210 cells.
    Li LH; Cowie CH
    Biochim Biophys Acta; 1974 Jul; 353(3):375-84. PubMed ID: 4368454
    [No Abstract]   [Full Text] [Related]  

  • 19. On the characteristics of inhibition of deoxyribonucleic acid synthesis by 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine.
    Kessel D
    Biochem Pharmacol; 1974 Oct; 23(19):2657-62. PubMed ID: 4420738
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
    Shapiro WR
    Cancer Res; 1972 Oct; 32(10):2178-85. PubMed ID: 5080762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.